Apollo Tyres FY26 Annual Earnings Summary
3 quarters covered · ₹21,910 Cr revenue · ₹0 Cr PAT · 14.9% average EBITDA margin.
Quarter-by-quarter progression
Management promises made during the year
Promise tracking available after 2+ quarters of coverage.
Risks flagged during the year
Mid-to-high teens sequential increase in Q1 FY27, with potential for further rise in Q2.
Q2 FY26 · mediumA financially strong new player is entering PCR and TBR segments, potentially increasing competitive intensity and pricing pressure.
Q2 FY26 · mediumEuropean market remains challenging with low single-digit growth expected; recovery is not yet assured.
Q2 FY26 · mediumWhile raw materials are currently stable, any upturn could pressure margins, especially given competitive pricing dynamics.
Q3 FY26 · mediumEurope market growth was -4% in Q3, and recovery is uncertain; continued weakness could delay margin improvement.
Q3 FY26 · mediumGlobal events cause unpredictable swings in raw material prices; management expects flattish costs but cannot rule out adverse moves.
Q3 FY26 · mediumThe large CapEx cycle could temporarily depress ROCE, which is currently 13.5%, below the 15% target.
Q4 FY26 · mediumAnalyst raised concern that repeated price increases and diesel price hikes could impact fleet operator profitability and demand.
Q4 FY26 · mediumDespite Enschede closure, sluggish market conditions and high energy costs may delay margin improvement beyond H2 FY27.
Q4 FY26 · mediumManagement noted Europe is a price follower; if competitors delay hikes, Apollo may struggle to pass on costs.
Q2 FY26 · lowApollo lost ground in PCR OEM shares due to not bidding for certain unprofitable businesses, which may impact future volumes.
Q3 FY26 · lowElevated A&P spend due to BCCI sponsorship may take time to normalize, impacting near-term margins.
What changed through the year
Q2 FY26 · H2 revenue growth to sustain or improve
Management expects Q3 revenue growth to be at least at Q2 levels, driven by GST benefits and brand investments.
Q2 FY26 · EBITDA margin to sustain or improve in H2
Profitability expected to remain at current levels or improve, supported by stable raw material costs and operating leverage.
Q2 FY26 · India replacement demand to grow mid-to-high single digits
Replacement demand expected to improve from current low levels to mid-to-high single digit growth.
Q2 FY26 · Enschede closure by end June 2026
Production closure at Enschede plant expected by end June 2026, with payback period of about two years on EUR 55 million cash costs.
Q3 FY26 · CapEx of ₹5,800 crore for Andhra Pradesh expansion over FY27-29
Board approved ₹5,800 crore CapEx for expanding PCR and TBR capacities in Andhra Pradesh, spread over FY27-29, with growth CapEx of ~₹2,000 crore in FY27.
Q3 FY26 · Consolidated CapEx of ~₹3,000 crore in FY27
Overall consolidated CapEx for FY27 is expected to be around ₹3,000 crore, including Hungary expansion and maintenance.
Q3 FY26 · A&P spend to normalize to 2.5% of sales
A&P spend as a percentage of sales will increase to about 2.5% in a normalized scenario, up from ~2% historically, to drive top-line growth.
Q3 FY26 · Enschede plant closure by end June 2026
The Netherlands plant will stop production by end of June 2026, with benefits expected to flow from H2 FY27.
Q4 FY26 · Price increases of 6-8% in India in Q1 FY27
Two rounds of price hikes implemented, with 3-5% already effective and remainder in May.
Q4 FY26 · CapEx of INR 35 billion for FY27
Nearly 80% allocated to India for capacity expansion in truck and car tires.
Q4 FY26 · European margins to improve from H2 FY27
Post Enschede closure, cost competitiveness expected to lift margins above current levels.
Q4 FY26 · Further price increases needed beyond 6-8%
Management indicated at least two more rounds of price hikes required to fully offset raw material inflation.